Kleiner Device Labs, founded with a mission to innovate spinal surgery, focuses on developing advanced medical devices that enhance the efficiency and safety of surgical procedures. Their flagship product, the Bi-Directional Graft Funnel (KG™1), is designed to work with any flowable biologic graft material, providing a more effective delivery system for bone graft extenders. This device facilitates grafting in front of or alongside all types of interbody cages, aiming to improve outcomes in spinal fusion surgeries. Kleiner Device Labs targets the spinal surgery market, offering solutions that streamline complex surgical processes.

Notable figures associated with Kleiner Device Labs include industry experts and seasoned professionals in medical device innovation. The company has garnered attention from investors interested in advancing surgical technologies. Key achievements include the successful development and market introduction of the KG™1 and subsequent products like the KG™2 SURGE™, which further enhance spinal fusion systems. Kleiner Device Labs has made a significant impact by providing surgeons with tools that improve procedural efficiency and patient safety, positioning itself as a leader in spinal surgery innovation.